NASDAQ:ACB Aurora Cannabis (ACB) Stock Price, News & Analysis $3.92 0.00 (0.00%) Closing price 10/2/2026 04:00 PM EasternExtended Trading$3.90 -0.02 (-0.64%) As of 10/2/2026 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Aurora Cannabis Stock (NASDAQ:ACB) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Aurora Cannabis alerts:Sign Up Key Stats Today's Range$3.87▼$3.9750-Day Range$2.72▼$4.2752-Week Range$2.56▼$6.66Volume682,005 shsAverage Volume730,000 shsMarket Capitalization$257.62 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingModerate Buy Company Overview Aurora Cannabis Inc. is a Canadian cannabis company focused primarily on the production, distribution and sale of medical cannabis. The company offers cannabis products such as dried flower, pre-rolls, oils, softgels, capsules and other formulations through its medical and consumer brands. Founded in 2013 and headquartered in Edmonton, Alberta, Aurora serves adult-use and medical markets in Canada and supplies medical cannabis to selected international markets. Its international operations and partnerships have included markets in Europe, Australia and other regions where cannabis is permitted for medical use. Aurora sells products under brands including Aurora, CanniMed, MedReleaf and San Rafael '71. The company is led by Chief Executive Officer Miguel Martin and is listed on the Nasdaq Capital Market under the symbol ACB.AI Generated. May Contain Errors. Read More Aurora Cannabis Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks19th Percentile Overall ScoreACB MarketRank™: Aurora Cannabis scored higher than 19% of companies evaluated by MarketBeat, and ranked 799th out of 887 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.9 / 5Analyst RatingModerate Buy Consensus RatingAurora Cannabis has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, 1 buy rating, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageAurora Cannabis has only been the subject of 3 research reports in the past 90 days.Read more about Aurora Cannabis' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Aurora Cannabis are expected to grow in the coming year, from ($0.07) to $0.06 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Aurora Cannabis is -2.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aurora Cannabis is -2.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAurora Cannabis has a P/B Ratio of 0.63. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Aurora Cannabis' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted11.48% of the float of Aurora Cannabis has been sold short.Short Interest Ratio / Days to CoverAurora Cannabis has a short interest ratio ("days to cover") of 8.45.Change versus previous monthShort interest in Aurora Cannabis has recently increased by 1.82%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAurora Cannabis does not currently pay a dividend.Dividend GrowthAurora Cannabis does not have a long track record of dividend growth. News and Social Media1.4 / 5News Sentiment-0.72 News SentimentAurora Cannabis has a news sentiment score of -0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.44 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Aurora Cannabis this week, compared to 4 articles on an average week.Search InterestOnly 2 people have searched for ACB on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.MarketBeat Follows7 people have added Aurora Cannabis to their MarketBeat watchlist in the last 30 days. This is an increase of 40% compared to the previous 30 days. Company Ownership0.6 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Aurora Cannabis insiders have not sold or bought any company stock.Percentage Held by Insiders0.01% of the stock of Aurora Cannabis is held by insiders.Percentage Held by Institutions47.63% of the stock of Aurora Cannabis is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Aurora Cannabis' insider trading history. Receive ACB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aurora Cannabis and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ACB Stock News HeadlinesAurora Cannabis (NASDAQ:ACB) and Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) Critical ReviewOctober 1, 2026 | americanbankingnews.comS&P/TSX Composite Index Falls to Two-Month Low in Choppy Trade As Healthcare Sector Shares TumbleSeptember 30, 2026 | finance.yahoo.comIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially the reasons why we’re bombing the country. | Banyan Hill Publishing (Ad)Curaleaf's Hostile Takeover Attempt of Aurora Cannabis Is Hitting Turbulence. Here's What Investors Should Watch.September 26, 2026 | fool.comAurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid DisclosureSeptember 23, 2026 | finance.yahoo.comAurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid DisclosureSeptember 23, 2026 | prnewswire.comBull of the Day: Aurora Cannabis (ACB)September 23, 2026 | finance.yahoo.comCuraleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid (ACB)Curaleaf took a hostile, $4-per-share cash-and-stock tender offer for Aurora Cannabis directly to shareholders after private merger talks stalled, seeking global scale ahead of federal cannabis reforms.September 15, 2026 | marketbeat.comSee More Headlines ACB Stock Analysis - Frequently Asked Questions How have ACB shares performed this year? Aurora Cannabis' stock was trading at $4.22 on January 1st, 2026. Since then, ACB shares have decreased by 7.1% and is now trading at $3.92. How were Aurora Cannabis' earnings last quarter? Aurora Cannabis Inc. (NASDAQ:ACB) posted its quarterly earnings results on Wednesday, August, 5th. The company reported $0.04 earnings per share for the quarter, topping the consensus estimate of ($0.13) by $0.17. The company earned $47.62 million during the quarter, compared to analyst estimates of $47.45 million. Aurora Cannabis had a negative net margin of 32.26% and a positive trailing twelve-month return on equity of 4.37%. Read the conference call transcript. When did Aurora Cannabis' stock split? Shares of Aurora Cannabis reverse split on Tuesday, February 20th 2024.The 1-10 reverse split was announced on Tuesday, February 20th 2024. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. Does Aurora Cannabis have any subsidiaries? Aurora Cannabis subsidiaries include these companies: Reliva LLC, Whistler Medical Marijuana Corporation, ICC Labs Inc., Anandia Labs Inc, MedReleaf Corp., CanniMed Therapeutics Inc., Larssen Ltd, and more. How do I buy shares of Aurora Cannabis? Shares of ACB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Aurora Cannabis own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aurora Cannabis investors own include Canopy Growth (CGC), Cronos Group (CRON), NVIDIA (NVDA), Meta Platforms (META), Humana (HUM), American Water Works (AWK). Company Calendar Last Earnings8/05/2026Today10/04/2026Next Earnings (Estimated)11/04/2026Fiscal Year End3/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 13 days, ACB's financial health has been in the Green zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:ACB Previous SymbolNYSE:ACB CIK1683541 Webauroramj.com Phone(604) 362-5207FaxN/AEmployees1,028Year Founded2006Profitability EPS (Trailing Twelve Months)($1.41) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$88.13 million Net Margins-32.26% Pretax Margin-11.84% Return on Equity4.37% Return on Assets3.45% Debt Debt-to-Equity Ratio0.03 Current Ratio5.36 Quick Ratio2.80 Sales & Book Value Annual Sales$247.82 million Price / Sales1.04 Cash Flow$0.70 per share Price / Cash Flow5.58 Book Value$6.27 per share Price / Book0.63Miscellaneous Outstanding Shares65,720,000Free Float65,717,000Market Cap$257.62 million OptionableOptionable Beta0.63 Social Links The 7 Hottest IPO Stories of 2026MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free Report This page (NASDAQ:ACB) was last updated on 10/5/2026 by MarketBeat.com Staff. From Our PartnersThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurora Cannabis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurora Cannabis With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
